# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
By Todd Harrison via Cannabis Confidential (May 17)
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...
Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a m...
The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more...
Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state op...
In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewi...
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legisla...
Roth MKM analyst Scott Fortune maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and raises the price target from $16 to $19.